Retroviral vectors provide a safe and efficient method of introducing genes of therapeutic interest into dividing cells. The principle limitation of these vectors in the past has been poor gene expression in vivo. This problem has been overcome recently through the use of tissue-specific enhancers i
Retroviral vectors for persistent expression in vivo
β Scribed by Robert K. Naviaux; Inder M. Verma
- Book ID
- 113404881
- Publisher
- Elsevier Science
- Year
- 1992
- Tongue
- English
- Weight
- 137 KB
- Volume
- 2
- Category
- Article
- ISSN
- 0960-9822
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Background Because gene therapy of the future will primarily take an __in vivo__ approach, a number of problems associated with its current implementation exist. Currently, repeated delivery of a vector __in vivo__ is necessary to ensure adequate transfer of the therapeutic gene. Th
## Background: A major prerequisite for the design of retroviral vectors encoding cell toxic or harmful genes is the possibility to tightly control gene expression, thus limiting activity to the relevant target cells and protecting the packaging cell used for production of recombinant viral particl